未登录

K

Kevin Lu

university of south carolina

H指数:25

被引数:2,636

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Causal effect of conventional anti-dementia drugs on economic burden: an orthogonal double/debiased machine learning approach

常规抗痴呆药物对经济负担的因果效应：一种正交双重/去偏机器学习方法

IF3.8

2025-08-270

OAAI

Economic outcomes of diabetes self-management education among older Medicare beneficiaries with diabetes

糖尿病自我管理教育在老年医疗保险受益人中的经济结果

health services research

IF3

2025-05-130

OA

Personalized Patient Data and Behavioral Nudges to Improve Adherence to Chronic Cardiovascular Medications

个性化患者数据和行为引导以提高对慢性心血管药物依从性

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

IF55

2025-05-130

PRE

Trajectories of pharmacological therapies for treatment-resistant depression: a longitudinal study

IF3.6

2025-03-100

OAAI

Predicting diabetes self-management education engagement: machine learning algorithms and models

BMJ OPEN DIABETES RESEARCH & CARE

IF4.1

2025-02-180

OAAI

Colorectal cancer burden, trends, and risk factors in China: rising incidence and disparities in the last 3 decades

中国结直肠癌负担、趋势及危险因素：过去30年的发病率上升与不平等现象

LANCET REGIONAL HEALTH-WESTERN PACIFIC

IF8.1

2025-02-011

OAAI

Cannabis Use, Disorders, and Disparities Under the Controlled Substances Act: NSDUH 2015-2019

JOURNAL OF GENERAL INTERNAL MEDICINE

IF4.2

2024-10-220

PRE

Handling time-varying treatments in observational studies: A scoping review and recommendations

bmj evidence based medicine

IF3.5

2024-03-192

PRE

Late-time window endovascular treatment is associated with neurological improvement: Evidence from the National Stroke Registry Data in China

CNS NEUROSCIENCE & THERAPEUTICS

IF5

2024-02-070

OAAI

National Volume-Based Procurement (NVBP) exclusively for insulin: towards affordable access in China and beyond

BMJ GLOBAL HEALTH

IF6.1

2024-01-162

OAAI

Role of artificial intelligence in pharmaceutical health care

人工智能在制药医疗保健中的作用

JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION

IF2.5

2024-01-012

PRE

Reporting, handling, and interpretation of time-varying drug treatments in observational studies using routinely collected healthcare data

bmj evidence based medicine

IF3.5

2023-12-181

PRE

Editorial: From clinical trials to real-world data sciences for value in health: access, utilization, and quality

FRONTIERS IN PUBLIC HEALTH

IF3.4

2023-05-310

OAAI

National value-based pricing negotiation for oncology drugs - lessons from China

NATURE REVIEWS CLINICAL ONCOLOGY

IF82.2

2023-05-123

PRE

Age and geographic disparities in acute ischaemic stroke prehospital delays in China: a cross-sectional study using national stroke registry data

LANCET REGIONAL HEALTH-WESTERN PACIFIC

IF8.1

2023-04-0110

OAAI

Editorial: From randomized clinical trials to real-world data and big data sciences: Generating evidence-based medicine for value in western and herbal medicines

FRONTIERS IN PUBLIC HEALTH

IF3.4

2023-02-132

OAAI

Estimates of Insulin Out-of-Pocket Cap-Associated Prescription Satisfaction, Adherence, and Affordability Among Medicare Beneficiaries

JAMA NETWORK OPEN

IF9.7

2023-01-137

OAAI

Why we should raise stroke awareness in the younger population?

CNS NEUROSCIENCE & THERAPEUTICS

IF5

2023-01-111

OA

Editorial: Family medicine and primary care: Best practice to achieve health equity for western and traditional Chinese medicine

FRONTIERS IN MEDICINE

IF3

2023-01-100

OA

Trends in prevalence, health disparities, and early detection of dementia: A 10-year nationally representative serial cross-sectional and cohort study

FRONTIERS IN PUBLIC HEALTH

IF3.4

2023-01-047

OAAI